Bridgeway Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bridgeway Capital Management’s Portfolio ELVN Stock Details ELVN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$245K	Hold
2023 Q2	$366K	Hold
2023 Q1	$393K	Sell
2022 Q4	$408K	Sell
2022 Q3	$288K	Hold
2022 Q2	$154K	Sell
2022 Q1	$267K	Buy
2021 Q4	$282K	Hold
2021 Q3	$511K	Buy